Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss drugs like finasteride may cause lasting sexual and mood side effects, and more research is needed to understand these risks.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

Finasteride may help reduce inappropriate sexual behaviors in dementia patients with prostate issues.

Hair loss in women linked to higher sexual dysfunction risk.

Testosterone patches can modestly improve sexual function in postmenopausal women not on estrogen therapy.

Testosterone Replacement Therapy can improve sexual health in postmenopausal women with low sexual desire, but more research is needed on its long-term effects.

Women with PCOS often have sexual problems, and treating these issues early can improve satisfaction and reduce healthcare costs.

5α-reductase inhibitors can cause serious and possibly lasting sexual and psychological side effects.

Finasteride's sexual side effects may be due to nocebo effect.

Girls conceived via assisted reproductive technologies show early puberty signs and larger ovaries.

Participating in Sexual Orientation Change Efforts may increase the risk of suicide for sexual minority individuals.

Certain medications can reduce sexual desire and function, especially in women.

Some medications can help increase sexual desire and function in women.

Flibanserin's effectiveness for low sexual desire in premenopausal women may vary based on hormone levels, with normal hormone levels showing better responses.

Many women experience sexual dysfunction, but few seek help, and better treatment and medical training are needed.

Female pattern hair loss does not significantly affect sexual dysfunction.

Finasteride for hair loss may cause long-lasting sexual side effects in young males.

Testosterone is important for men's sexual function, may help some women's sexual desire, while other hormones and neurotransmitters also play complex roles in sexual behavior.

The report recommends personalized treatment for women's sexual dysfunctions and more research on effective therapies.

Experts recommend thorough medical, sexual, and psychosocial assessments for women's sexual dysfunctions, and suggest individualized treatment plans with regular check-ups. They also mention potential use of estrogen and androgen therapy, but with caution due to safety concerns.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

Women with PCOS often feel stigmatized and have mood issues, which can lower their sexual satisfaction, but proper treatment and support can help.

DHEA did not improve sexual function, well-being, or menopausal symptoms in postmenopausal women with low libido but caused side effects like acne and increased facial hair.

Finasteride for hair loss has minimal impact on sexual function.

Finasteride may cause sexual side effects like erectile dysfunction, but they are reversible and affect less than 2% of men.

Finasteride doesn't reduce sexual function in people with hair loss.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Skin problems can be linked to sexual abuse, requiring careful medical and psychological evaluation.

Cyproterone acetate effectively treats sexual disorders by reducing sexual functions and is generally well-tolerated.

Older men should openly discuss sexual health with doctors to improve their quality of life.